Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 16,141 Maze Therapeutics, Inc. shares (Form 4)

Traded Sep 1, 2026 · Filed Sep 3, 2026

On Sep 1, 2026, Bernstein Harold (President, R&D & CMO) sold 16,141 Maze Therapeutics, Inc. shares at US$26.36 for US$425K under a trading plan, leaving 20,000 shares. Filed Sep 3, 2026 (Form 4).

Sold
16,141 shares
Price
US$26.36
Value
US$425K
Holding after
20,000 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D & CMO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 1, 2026Common StockOption exercise16,141US$10.4216,141Direct
Sep 1, 2026Common StockSale16,141US$26.360Direct
Sep 1, 2026Common StockOption exercise20,00020,000Direct

Source

View original at SEC

Related